Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY has floated a tender for Japanese Encephalitis Vaccine (JEV). The project location is USA and the tender is closing on 26 Sep 2025. The tender notice number is SPE2DP-26-R-0JEV, while the TOT Ref Number is 125274233. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country: USA
Summary: Japanese Encephalitis Vaccine (JEV)
Deadline: 26 Sep 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 125274233
Document Ref. No.: SPE2DP-26-R-0JEV
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
Sources Sought Notice for the Japanese Encephalitis Vaccine (JEV)
NSN: 6505-01-607-7018
ITEM IDENTIFICATION: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe
The Defense Logistics Agency Troop Support is seeking sources capable of providing the Japanese Encephalitis Vaccine (JEV). DLA Troop Support is contemplating awarding a one-year base indefinite delivery, indefinite quantity contract for the JEV. The contract minimum quantity is 200, 060 each. The estimated quantity is 208, 320 each and the contract maximum is 300, 300 each. However, the quantity may increase or decrease as the Services requirements change.
SALIENT CHARACTERISTICS
Shall be Japanese Encephalitis Virus Vaccine, Purified, Inactivated.
Shall be FDA-approved for active immunization against Japanese Encephalitis disease.
Shall be FDA-approved for administration to persons 2 months of age and up.
Shall be Vero Cell culture derived.
Shall be a sterile suspension.
Shall not contain any stabilizers.
Shall be Thimerosal/Preservative-free and Latex free.
Shall be suitable for intramuscular administration.
Shall be supplied as a sterile 0.5 ml suspension in a pre-filled syringe (Type 1 glass) with a plunger stopper (chlorobutyl elastomer) with or without a separate needle. Children 2 months to Shall have an expiration dating period of 24 months. Not less than 21 months of the expiration dating period shall remain at time of delivery to the Government.
Material shall be shipped under constant refrigeration: 2° - 8° C (35° - 46° F). No excursions permitted.
Do Not Freeze. Protect from light.
Unit. Each. One each (syringe) containing a single-dose pre-filled syringe, as specified, constitutes one unit.
For additional requirements please see the attachment to this announcement titled “JEV MPID 4”.
Awardee shall have FDA approval to sell the JEV before award decision.
If your f...
Active Contract Opportunity
Notice ID : SPE2DP-26-R-0JEV
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE LOGISTICS AGENCY
Major Command : TROOP SUPPORT MEDICAL
Office: DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Aug 27, 2025 11:59 am EDT
Original Response Date: Sep 26, 2025 11:59 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Oct 11, 2025
Initiative: None
Classification
Original Set Aside: No Set aside used
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing
Place of Performance: Philadelphia, PA 19111 USA
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google